The company's financial statements covering its activities for the year 2025, which have been independently audited and prepared in accordance with the Capital Markets Board regulations, Turkish Accounting Standards / Turkish Financial Reporting Standards, and the financial statements prepared from the records kept within the scope of tax laws were examined and discussed; Our company, Alkim Alkali Kimya Anonim Şirketi, has reported a net loss of TL 408,293,249 after tax for the accounting period of 01.01.2025-31.12.2025, as per the financial reports prepared in accordance with the provisions of the Capital Market Board's (SPK) Series: II-14.1 "Principles Regarding Financial Reporting in the Capital Market" Communiqué, Turkish Accounting Standards/Turkish Financial Reporting Standards ("TMS/TFRS"), and the Capital Market Board's Series II-14.1 "Principles Regarding Financial Reporting in the Capital Market" Communiqué. However, according to the financial statements prepared in accordance with legal records, a net profit of TL 36,361,220.81 was realized for the period. In order to strengthen our company's liquidity position and balance sheet structure by increasing its free cash, and taking into account the current year's loss according to IFRS records, it was decided at our Ordinary General Meeting of Shareholders, to discuss the 2025 operating results, that no dividend distribution will be made this year; that the current year's profit of TL 36,361,220.81 calculated according to the Turkish Tax Procedure Law (VUK) records will be transferred to retained earnings; and that the net period loss of TL 408,293,249 attributable to the parent company in the financial statements prepared according to IFRS/IAS principles will be transferred to retained earnings/losses. These matters were submitted to the approval of our shareholders and were accepted by the general meeting.
